Christel Thauvin‐Robinet

Healthcare professionals’ views on expanding newborn screening with or without genomics in France: Results of the SeDeN-p2 study

Abstract Therapeutic advances and the rapid, cost-effective development of next-generation sequencing (NGS) have increased interest in expanding newborn screening (NBS) through genomics. The SeDeN-p2 study assessed the acceptability among healthcare professionals in France, of ex...